{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:25:45Z","timestamp":1754112345717},"reference-count":51,"publisher":"Pensoft Publishers","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10,1]]},"abstract":"<jats:title>Immunopathological Characteristics of Cryptoglandular and Crohn's Anorectal Fistulas<\/jats:title><jats:p>Anorectal fistulas are quite common proctologic disorders. They can be either of cryptoglandular origin or can be associated with Crohn's disease and chronic ileocolitis. Mechanical obstruction and local infections are prime causes of this pathological condition. Genetic predisposition and inadequate immune response with overproduction of pro-inflammatory cytokines appear prominently in the course of Crohn's disease. Interferon-\u03b3, a Th1 type cytokine, reflecting the engagement of cellular immune mechanisms, is the first to be produced in the intestinal mucosa. The inflammatory process in the colon mucosa induced by the abundant microbial flora is sustained and turned chronic by the gradual elevation of the local TNF-\u03b1 and regulatory cytokines levels (interleukin-10, transforming growth factor-\u03b2). The number of activated local memory T cells CD4+CD45RB<jats:sup>lo<\/jats:sup>increases significantly. The regulatory CD4+CD25+ T lymphocytes producing interleukin-10 increase also trying to counterbalance the cytokine reaction. The chronic inflammatory infiltrates of the colon mucosa are represented by lymphocytes, plasma cells, macrophages. The long-term activation of macrophages by the released interferon-\u03b3 leads to tissue damage and potentiation of angiogenesis - a risk factor for carcinoma development. Management of anorectal abscesses and fistulas is complex aiming to alleviate the symptoms, prevent relapses, reduce the risk of sphincter damage and improve quality of life. The main approach (surgery) should be combined with antimicrobial infection control and immunomodulation by intravenous or local administration of anti-TNF-\u03b1 antibodies.<\/jats:p>","DOI":"10.2478\/v10153-010-011-4","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T01:09:06Z","timestamp":1304989746000},"page":"5-12","source":"Crossref","is-referenced-by-count":4,"title":["Immunopathological Characteristics of Cryptoglandular and Crohn's Anorectal Fistulas"],"prefix":"10.3897","volume":"52","author":[{"given":"Bozhidar","family":"Hadzhiev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Murdjeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2258","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1463-1318.2008.01483.x","article-title":"Surgical management of anal fistulae: a systematic review","volume":"10","author":"A. Malik","year":"2008","journal-title":"Colorectal Dis"},{"key":"2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/bjs.1800790304","article-title":"Anal fistula","volume":"79","author":"F. Seow-Choen","year":"1992","journal-title":"Br J Surg"},{"key":"3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s10350-005-0055-3","article-title":"Practice parameters for the treatment of perianal abscess and fistula-in-ano (revised)","volume":"48","author":"M. Whiteford","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"4","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/gast.2003.50148","article-title":"Emergence of perianal fistulizing disease in the SAMP1\/YitFc mouse, a spontaneous model of chronic ileitis","volume":"124","author":"J. Rivera-Nieves","year":"2003","journal-title":"Gastroenterology"},{"issue":"6","key":"5","first-page":"549","article-title":"Perianal fistulas in Crohn's disease: treatment results at an interdisciplinary unit","volume":"80","author":"I. Iesalnieks","year":"2009","journal-title":"Chirurg"},{"key":"6","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/BF02253493","article-title":"Clinical classification of perianal Crohn's disease","volume":"35","author":"L. Hughes","year":"1992","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cgh.2007.10.010","article-title":"Perianal fistulizing Crohn's disease: a call to action","volume":"6","author":"M. Kamm","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3748\/wjg.15.1315","article-title":"Long-term natural history of Crohn's disease","volume":"15","author":"H. Freeman","year":"2009","journal-title":"World J Gastroenterol"},{"key":"9","first-page":"135","article-title":"Immune mechanism in chronic inflammatory bowel disease","volume":"72","author":"C. Braegger","year":"1994","journal-title":"Ann Allergy"},{"key":"10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","article-title":"The clinical course of fistulating Crohn's disease","volume":"17","author":"S. Bell","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"11","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1286-4579(01)01456-3","article-title":"Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells","volume":"3911","author":"H. Weiner","year":"2001","journal-title":"Microbes Infect"},{"issue":"10","key":"12","doi-asserted-by":"crossref","first-page":"5342","DOI":"10.4049\/jimmunol.168.10.5342","article-title":"p38 mitogen-activated protein-kinase is activated and linked to TNF-alpha signalling in inflammatory bowel disease","volume":"168","author":"G. Waetzig","year":"2002","journal-title":"J Immunol"},{"issue":"4","key":"13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/cyto.2001.0919","article-title":"Infliximab downregulates interferon-gamma production in activated gut Tlymphocytes from patients with Crohn's disease","volume":"15","author":"J. Aghnolt","year":"2001","journal-title":"Cytokine"},{"key":"14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1046\/j.1365-2036.2003.01487.x","article-title":"Response, relapse and mucosal immune regulation after infliximab treatment in fistulating Crohn's disease","volume":"17","author":"J. Aghnolt","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"15","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","article-title":"Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial","volume":"116","author":"G. D'Haens","year":"1999","journal-title":"Gastroenterology"},{"issue":"1","key":"16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/13102818.2003.10819205","article-title":"Interleukin-1\u03b2 and interleukin-1ra serum and stool levels in the course of salmonellosis","volume":"17","author":"M. Stoycheva","year":"2003","journal-title":"Biotechnol Biotechnol Eq"},{"issue":"1","key":"17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00365540410026068","article-title":"Serum levels of interferon-gamma, interleukin-12, tumor necrosis factor-alpha, and interleukin-10, and bacteriological clearance in patients with gastroenteric salmonella infections","volume":"37","author":"M. Stoycheva","year":"2005","journal-title":"Scand J Infect Di"},{"issue":"1","key":"18","first-page":"78","article-title":"A study on proinflammatory cytokines (IL-1beta, IL-6, TNF-alpha) and IL-12 in patients with acute hepatitis B","volume":"XXXI","author":"M. Geneva-Popova","year":"1999","journal-title":"Folia Medica"},{"issue":"1","key":"19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0168-8278(01)81681-0","article-title":"Rickettsia induced liver injury: histopathologic findings and cytokine profile","volume":"34","author":"N. Popivanova","year":"2001","journal-title":"Journal of Hepatology"},{"issue":"11","key":"20","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1128\/JCM.35.11.2974-2976.1997","article-title":"The aerobic and anaerobic bacteriology of perianal abscesses","volume":"35","author":"I. Brook","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"XLIII","key":"21","first-page":"43","article-title":"Microbiological and immunological aspects in patients with anorectal abscesses and fistulae","author":"T. Dermendjiev","year":"2006","journal-title":"Infectology"},{"issue":"11","key":"22","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/BF02237048","article-title":"Incidence of fistulas after drainage of acute anorectal abscesses","volume":"41","author":"K. Hamalainen","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"8","key":"23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1155\/1997\/237085","article-title":"Atypical perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease","volume":"11","author":"H. Freeman","year":"1997","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"24","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(98)70204-0","article-title":"Cow's milk-protein allergy as a cause of anal fistula and fissures: a case report","volume":"101","author":"G. Iacono","year":"1998","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infection of intestinal contents in excluded ileum","volume":"114","author":"G. D'Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"26","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/gut.2005.070201","article-title":"Elevated anal squamous cell carcinoma risk associated with benign inflammatory anal lesions","volume":"55","author":"S. Nordenvall","year":"2006","journal-title":"Gut"},{"issue":"1","key":"27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/000313480807400113","article-title":"Adenocarcinoma arising from chronic perianal Crohn's disease: case report and review of the literature","volume":"74","author":"R. Smith","year":"2008","journal-title":"Am Surg"},{"key":"28","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/00365520600609941","article-title":"Tretament of perianal fistulas in Crohn's disease by local injection of antibody to TNF-\u03b1 accounts for a favourable clinical response in selected case: a pilot study","volume":"41","author":"C. Asteria","year":"2006","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.gtc.2009.07.009","article-title":"Treatment of fistulizing inflammatory bowel disease","volume":"38","author":"D. Schwartz","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"30","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000228579","article-title":"Fistula treatment: the unresolved challenge","volume":"27","author":"P. Michetti","year":"2009","journal-title":"Dig Dis"},{"issue":"34","key":"31","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.3748\/wjg.15.4263","article-title":"Emerging treatments for complex perianal fistula in Crohn's disease","volume":"15","author":"C. Taxonera","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"4","key":"32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1159\/000233299","article-title":"Treatment algorithms in the case of perianal complications of Crohn's disease","volume":"27","author":"Y. Lozynskyy","year":"2009","journal-title":"Dig Dis"},{"issue":"6","key":"33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bjs.6608","article-title":"Outcome of surgical treatment for fistula in ano in Crohn's disease","volume":"96","author":"P. Van Koperen","year":"2009","journal-title":"Br J Surg"},{"key":"34","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/gut.37.5.696","article-title":"Clinical course of perianal fistulas in Crohn's disease","volume":"37","author":"F. Marcowiec","year":"1995","journal-title":"Gut"},{"issue":"3","key":"35","first-page":"41","article-title":"Treatment of chronic anorectal fistulas by fibrin sealant","author":"B. Hadzhiev","year":"2008","journal-title":"Khirurgiia"},{"issue":"3","key":"36","first-page":"231","article-title":"Modern methods of occlusive treatment of anorectal fistula","volume":"41","author":"B. Hadzhiev","year":"2009","journal-title":"Scripta Scientifica Medica"},{"issue":"6","key":"37","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ibd.20739","article-title":"Closure of perianal fistula using Adalimumab in a Crohn's disease patients naive to anti-tumor necrosis factor alpha antibodies","volume":"15","author":"A. Malesci","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1572-0241.1999.00848.x","article-title":"Hyperbaric oxygen therapy for perianal Crohn's disease","volume":"94","author":"C. Noyer","year":"1999","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/138945010790309939","article-title":"Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review","volume":"11","author":"A. Oussalah","year":"2009","journal-title":"Curr Drug Targets"},{"issue":"5","key":"40","first-page":"356","article-title":"Biologic therapy in Crohn's disease","volume":"106","author":"M. Williams","year":"2009","journal-title":"Mo Med"},{"issue":"2","key":"41","article-title":"Mechanisms of action of infliximab in inflammatory bowel disease: an anti-inflammatory multitasker","volume":"40","author":"S. Danese","year":"2008","journal-title":"Dig Liver Dis"},{"key":"42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1053\/j.gastro.2003.11.014","article-title":"Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease","volume":"126","author":"P. Rutgeerts","year":"2004","journal-title":"Gastroenterology"},{"key":"43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"B. Sands","year":"2004","journal-title":"N Eng J Med"},{"issue":"1","key":"44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1365-2036.2009.04130.x","article-title":"The efficacy and safety of a third anti-TNF monoclonal anti-body in Crohn's disease after failure of two other anti-TNF antibodies","volume":"31","author":"M. Allez","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0016-5085(03)00701-7","article-title":"Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study","volume":"125","author":"S. Vermeire","year":"2003","journal-title":"Gastroenterology"},{"key":"46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1542-3565(04)00238-1","article-title":"Incidence and importance of antibody response to infliximab after maintenance or episodic treatments in Crohn's disease","volume":"2","author":"S. Hanauer","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"47","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"L. Carmota","year":"2005","journal-title":"Arthritis Rheum"},{"key":"48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s10350-004-0832-4","article-title":"Local injection of infliximab for the treatment of perianal Crohn's disease","volume":"48","author":"G. Poggioli","year":"2005","journal-title":"Dis Colon Rectum"},{"key":"49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1572-0241.2004.04083.x","article-title":"Type of fistula determines response to infliximab in patients with fistulous Crohn's disease","volume":"99","author":"M. Parsi","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","article-title":"Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial","volume":"130","author":"S. Hanauer","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"51","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn's disease","volume":"58","author":"J. Colombel","year":"2009","journal-title":"Gut"}],"container-title":["Folia Medica"],"original-title":[],"link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/folmed\/52\/4\/article-p5.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/versita.metapress.com\/openurl.asp?genre=article&id=doi:10.2478\/v10153-010-011-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:30:22Z","timestamp":1637627422000},"score":1,"resource":{"primary":{"URL":"http:\/\/content.sciendo.com\/view\/journals\/folmed\/52\/4\/article-p5.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,1]]},"references-count":51,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2478\/v10153-010-011-4","relation":{},"ISSN":["1314-2143","0204-8043"],"issn-type":[{"value":"1314-2143","type":"electronic"},{"value":"0204-8043","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10,1]]}}}